GPX3 encodes glutathione peroxidase 3, a selenium-dependent enzyme that neutralizes reactive oxygen species and protects extracellular fluids from oxidative damage.
As the only secreted member of the glutathione peroxidase family, GPX3 plays important roles in cardiovascular health, kidney function, cancer biology, and metabolic regulation.
The GPX3 gene provides instructions for making glutathione peroxidase 3 (GPX3), a selenium-containing enzyme that protects the body from oxidative damage. It is also known as plasma glutathione peroxidase, and it belongs to the glutathione peroxidase family.
GPX3 is a selenoprotein containing the amino acid selenocysteine, which is critical for its activity. The enzyme uses glutathione (GSH) to neutralize harmful molecules called reactive oxygen species (ROS), including hydrogen peroxide (H₂O₂) and organic hydroperoxides.
GPX3 is upregulated in hypoxic conditions.
GPX3 catalyzes the following key antioxidant reaction:
2 GSH + H₂O₂ → GSSG + 2 H₂O
This reduces harmful peroxides to water and protects cells from oxidative stress.
Unlike other members of its family, GPX3 is secreted and found mainly in extracellular fluids, including plasma, lymph, and lung fluid.
It is produced primarily by kidney proximal tubule cells and is also expressed in the liver, lungs, and gastrointestinal tract.
GPX3 testing may be relevant in the following scenarios:
GPX3 is not a routine lab test but is often measured in research or specialized clinical studies exploring its role in:
Since GPX3 is a selenium-dependent enzyme, dietary selenium can influence its levels. However, direct selenium testing is more accurate for assessing selenium status.
Low GPX3 may have the following consequences:
Low GPX3 levels may indicate a reduced ability to neutralize ROS, which can contribute to:
Research has linked low GPX3 levels with:
Low dietary selenium can impair GPX3 production and function.
Elevated GPX3 levels are poorly understood but may represent a compensatory response to oxidative stress. In some cancers (e.g., clear cell ovarian cancer), high GPX3 levels may support tumor survival, though this is context-dependent.
GPX3 is the only extracellular glutathione peroxidase, vital for protecting plasma and tissues from oxidative stress.
It plays key roles in cardiovascular health, renal function, cancer biology, and insulin signaling in adipose tissue.
Low GPX3 levels may reflect oxidative stress, selenium deficiency, or disease progression.
GPX3 expression is regulated by selenium availability, transcription factors (e.g., Sp1, HIF-1), and promoter methylation.
It shows promise as a biomarker and potential therapeutic target in diseases related to oxidative stress and metabolism.
Bierl, C., Voetsch, B., Jin, R. C., Handy, D. E., & Loscalzo, J. (2004). Determinants of Human Plasma Glutathione Peroxidase (GPx-3) Expression. Journal of Biological Chemistry, 279(26), 26839–26845. https://doi.org/10.1074/jbc.m401907200
Gene Database. (2025). GPX3 Gene - GeneCards | GPX3 Protein | GPX3 Antibody. Genecards.org. https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPX3
GPX3 glutathione peroxidase 3 [Homo sapiens (human)] - Gene - NCBI. (2025). Nih.gov. https://www.ncbi.nlm.nih.gov/gene/2878
Hauffe, R., Stein, V., Chudoba, C., Flore, T., Rath, M., Ritter, K., Schell, M., Wardelmann, K., Deubel, S., Kopp, J. F., Schwarz, M., Kappert, K., Blüher, M., Schwerdtle, T., Kipp, A. P., & Kleinridders, A. (2020). GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity. JCI Insight. https://doi.org/10.1172/jci.insight.136283
He, Q., Chen, N., Wang, X., Li, P., Liu, L., Rong, Z., Liu, W., Jiang, K., & Zhao, J. (2023). Prognostic value and immunological roles of GPX3 in gastric cancer. International Journal of Medical Sciences, 20(11), 1399–1416. https://doi.org/10.7150/ijms.85253
Nirgude, S., & Choudhary, B. (2020). Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochemical Pharmacology, 184, 114365. https://doi.org/10.1016/j.bcp.2020.114365
Pastori, D., Pignatelli, P., Alessio Farcomeni, Menichelli, D., Nocella, C., Carnevale, R., & Violi, F. (2016). Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation. Journal of the American Heart Association, 5(9). https://doi.org/10.1161/jaha.116.003682
Zhang N, Liao H, Lin Z, Tang Q. Insights into the Role of Glutathione Peroxidase 3 in Non-Neoplastic Diseases. Biomolecules. 2024 Jun 13;14(6):689. doi: 10.3390/biom14060689. PMID: 38927092; PMCID: PMC11202029.
Zou, Z., Ren, T., Li, Y., Zeng, Q., Wang, X., Teng, J., Xu, J., Jia, P., & Ding, X. (2023). The Association Between Serum Glutathione Peroxidase-3 Concentration and Risk of Acute Kidney Injury After Cardiac Surgery: A Nested Case-Control Study. The American Journal of Cardiology, 209, 29–35. https://doi.org/10.1016/j.amjcard.2023.08.141